CompletedNot Applicable

Validation of the ICH Score for the Prediction of 12-month Functional Outcome in Patients With Primary Intracerebral Hemorrhage

Taiwan100 participantsStarted 2019-06-24

Plain-language summary

The goal of this observational study is to analyze the validity of the intracerebral hemorrhage (ICH) Score and a new modified ICH score for the prediction of 12-month functional outcome in patients with primary ICH. Participants who were admitted to NTUH rehabilitation ward will be followed up to 12 months after the onset of ICH. The follow-up will be conducted by phone interviews.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 20 years or older * Had been admitted to a neurology, neurosurgery, or rehabilitation ward with a diagnosis of primary intracerebral hemorrhage (ICH) * Had a diagnosis of ICH confirmed by a brain computed tomography (CT) * Have written informed consent given by themselves or by their legal representative Exclusion Criteria: * ICH related to aneurysm, arteriovenous malformation, or trauma * Died before discharge

What they're measuring

Barthel index

Timeframe: 12-month after ICH onset

Modified Rankin scale

Timeframe: 12-month after ICH onset

Trial details

NCT IDNCT05808777

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-06-23

View on ClinicalTrials.gov More Intra Cerebral Hemorrhage trials